Kinetics of the development and recovery of the lung from IgE-mediated inflammation: Dissociation of pulmonary eosinophilia, lung injury, and eosinophil-active cytokines

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 2, 1997, Pages 442-448

  Shaver, Joseph R ^a   Zangrilli, James G ^a   Cho, Seung Kil ^a,b   Cirelli, Rosemary A ^a,c   Pollice, Mary ^a   Hastie, Annette T ^a   Fish, James E ^a   Peters, Stephen P ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Chung Ang University   (South Korea)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

AIRWAY PRESSURE; ALLERGIC ASTHMA; ANTIGEN FUNCTION; ARTICLE; BRONCHOSCOPY; CELL ACTIVATION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; HYPOTHESIS; LUNG LAVAGE; PNEUMONIA; PRIORITY JOURNAL; PROVOCATION TEST; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

EID: 0031052842     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.2.9032176     Document Type: Article

References (28)

1. 2 into human airways during acute antigen challenge. N. Engl. J. Med. 315:800-804.
2. Metzger, W. J., D. Zavala, H. B. Richerson, P. Moseley, P. Iwamota, M. Monick, K. Sjoerdsma, and G. W. Hunninghake. 1987. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am. Rev. Respir. Dis. 135:433-440.
3. Wenzel, S. E., A. A. Fowler, III, and L. B. Schwartz. 1988. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am. Rev. Respir. Dis. 137:1002-1008.
4. Wenzel, S. E., J. Y. Westcott, H. R. Smith, and G. L. Larsen. 1989. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. 1989. Am. Rev. Respir. Dis. 139:450-457.
5. Liu, M. C., W. C. Hubbard, D. Proud, B. A. Stealey, S. J. Galli, A. Kagey-Sobotka, E. R. Bleecker, and L. M. Lichtenstein. 1991. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediators, and permeability changes. Am. Rev. Respir. Dis. 144:51-58.
6. Sedgwick, J. B., W. J. Calhoun, G. J. Gleich, H. Kita, J. S. Abrams, L. B. Schwartz, B. Volovotz, M. Ben-Yaakov, and W. W. Busse. 1991. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am. Rev. Respir. Dis. 144:1274-1281.
7. Dupuis, R., D. S. Collins, Y. Y. Koh, M. Pollice, K. H. Albertine, J. E. Fish, and S. P. Peters. 1992. Effect of antigen dose on the recruitment of inflammatory cells to the lung by segmental antigen challenge. J. Allergy Clin. Immunol. 89:850-857.
8. Aalbers, R., H. F. Kaufman, B. Vrugt, G. H. Koëter, and J. G. R. de Monchy. 1993. Allergen-induced recruitment of inflammatory cells in lavage 3 and 24 h after challenge in allergic asthmatic lungs. Chest 103:1178-1184.
9. Collins, D. S., R. Dupuis, G. J. Gleich, K. R. Bartemes, Y. Y. Koh, M. Pollice, K. H. Albertine, J. E. Fish, and S. P. Peters. 1993. Immunoglobulin E-mediated increase in vascular permeability correlates with eosinophilic inflammation. Am. Rev. Respir. Dis. 147:677-683.
10. Calhoun, W. J., N. N. Jarjour, G. J. Gleich, C. A. Stevens, and W. W. Busse. 1993. Increased airway inflammation with segmental versus aerosol antigen challenge. Am. Rev. Respir. Dis. 147:1465-1471.
11. Montefort, S., C. Gratziou, D. Goulding, R. Polosa, D. O. Haskard, P. H. Howarth, S. T. Holgate, and M. P. Carroll. 1994. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest. 93:1411-1421.
12. Virchow, J.-C., Jr., C. Walker, D. Haefner, C. Korstik, P. Werner, H. Matthys, and C. Kroegel. 1995. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen provocation in atopic asthma. Am. J. Respir. Crit. Care Med. 151:960-968.
13. Zangrilli, J. G., J. R. Shaver, R. A. Cirelli, S. K. Cho, C. G. Garlisi, A. Falcone, F. M. Cuss, J. E. Fish, and S. P. Peters. 1995. sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am. J. Respir. Crit. Care Med. 151:1346-1353.
14. Shaver, J. R., J. J. O'Connor, M. Pollice, S. K. Cho, G. C. Kane, J. E. Fish, and S. P. Peters. 1995. Pulmonary inflammation after segmentai ragweed challenge in allergic asthmatic and nonasthmatic subjects. Am. J. Respir. Crit. Care Med. 152:1189-1197.
15. Huang, S.-K., H.-Q. Xiao, J. Kleine-Tebbe, G. Paciotti, D. G. Marsh, L. M. Lichtenstein, and M. C. Liu. 1995. IL-13 expression at sites of allergen challenge in patients with asthma. J. Immunol. 155:2688-2694.
16. Gratziou, C., M. Carroll, S. Montefort, L. Teran, P. H. Howarth, and S. T. Holgate. 1996. Inflammatory and T-cell profile of asthmatic airways 6 hours after local allergen provocation. Am. J. Respir. Crit. Care Med. 153:515-520.
17. Sheffer, A. A. 1991. National Asthma Education Program. Expert Panel Report. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. Publication No. 91-3042.
18. Bentley, A. M., Q. Meng, D. S. Robinson, Q. Hamid, A. B. Kay, and S. R. Durham. 1993. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am. J. Respir. Cell Mol. Biol. 8:35-42.
19. Woolley, K. L., E. Adelroth, M. J. Woolley, I. Ramis, J. S. Abrams, M. Jordana, and P. M. O'Byrne. 1996. Interleukin-3 in bronchial biopsies from nonasthmatics and patients with mild and allergen-induced asthma. Am. J. Respir. Crit. Care Med. 153:350-355.
20. Kane, G. C., M. Tolino, M. Pollice, C. J. Kim, J. Cohn, J. J. Murray, R. Dworski, J. Sheller, J. E. Fish, and S. P. Peters. 1995. Insights into IgE-mediated lung inflammation derived from a study employing a 5-lipoxygenase inhibitor. Prostaglandins 50:1-18.
21. Hamid, Q., M Azzawi, S. Ying, R. Moqbel, A. J. Wardlaw, C. J. Corrigan, B. Bradley, S. R. Durham, J. V. Collins, P. K. Jeffery, D. J. Quint, and A. B. Kay. 1991. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541-1546.
22. Broide, D. H., M. M. Paine, and G. S. Firestein. 1992. Eosinophils express interleukin-5 and granulocyte-macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1414-1424.
23. Ohnishi, T., S. Sur, D. S. Collins, J. E. Fish, G. J. Gleich, S. P. Peters. 1993. Eosinophil survival activity identified as IL-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen challenge. J. Allergy Clin. Immunol. 92:607-615.
24. Sur, S., G. J. Gleich, M. C. Swanson, K. R. Bartemes, and D. H. Broide. 1995. Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J. Allergy Clin. Immunol. 96:661-668.
25. Sullivan, S., and D. H. Broide. 1996. Compartmentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma. J. Allergy Clin. Immunol. 97:966-976.
26. Sousa, A. R., R. N. Poston, S. J. Lake, J. A. Nakhosteen, and T. H. Lee. 1993. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am. Rev. Respir. Dis. 147:1557-1561.
27. Ihle, J. N., J. Keller, S. Oroszalan, L. E. Henderson, T. D. Copeland, F. Fitch, M. B. Prystowshy, E. Goldwasser, and J. W. Schrader. 1983. Biologic properties of homogeneous interleukin-3. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P cell-stimulating activity and histamine-producing cell-stimulating activity. J. Immunol. 131:282-287.
28. O'Connor, J., G. C. Kane, M. Tolino, M. Pollice, J. E. Fish, and S. P. Peters. 1995. Inhaled albuterol does not inhibit cellular influx or lung injury produced by segmental antigen challenge in humans. Pulm. Pharmacol. 8:237-243.